Bayer and Monsanto are doing what is necessary to make the acquition palatable to USA and EUR authorities. ALL ON TRACK FOR $128 PPS. BUY-OUT WITHIN THIS YEAR.
Merger timeline information: EU initial review results due by Aug 7.
@@@On June 30, the German chemical giant notified its Monsanto takeover bid to the EU, allowing the companies until July 31 to submit antitrust concessions in “phase I” and setting an initial Aug. 7 deadline for the review. While Bayer Chief Executive Officer Werner Baumann said in June that it’s realistic to close the deal by the end of the year, describing talks with the EU as “very good and constructive,” an EU move to open an in-depth Phase II investigation would push a deadline out until Dec. 28 at the earliest. Any additional delay -- such as a stopped clock to allow the firms to gather relevant data for the EU -- would make it impossible for Bayer to close the deal by the end of the year.
Bayer Faces EU Test in Race to Close Monsanto Deal by Year-End
Bayer AG’s plan to ward off an in-depth European Union investigation into its $66 billion combination with Monsanto Co. faces a test at a meeting early next week that could jeopardize their goal of closing the deal this year.
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0 In other words, the correlation coefficient of the other stocks is
Farmers' estimates of herbicide damage top 120,000 acres
Complaints of crop damage in Arkansas possibly caused by a herbicide topped 700 this week, and preliminary estimates put the damaged cropland at 122,000 acres, a subcommittee of the state Plant Board was told Friday.
"Rowland oversaw the EPA’s cancer assessment for glyphosate, the key ingredient in Monsanto’s weed-killing products, and was a key author of a report finding glyphosate was not likely to be carcinogenic."
Questions about EPA-Monsanto collusion raised in cancer lawsuits
'According to a Monsanto email, a Monsanto employee said EPA official Jess Rowland said he "should get a medal" if he could kill a different government agency's investigation into glyphosate.'
Patients: Roundup gave us cancer as EPA official helped the company
Christine Sheppard is one of more than 800 cancer patients suing Monsanto, the maker of Roundup, claiming the company failed to warn consumers about a risk of cancer from the weed killer. Monsanto insists Roundup is safe.
Iowa’s resistant weed problem: what Canadian farmers can learn - The Western Producer
SCHLESWIG, Iowa — Driving on Interstate 80, west of Des Moines, the land rolls more than many people might expect. There are also tree bluffs, […]
"...traces of glyphosate have been detected in cookies, crackers, chips, breakfast cereals, and honey, and in human urine and breast milk. Monsanto says it’s nothing to worry about."
Does the World’s Top Weed Killer Cause Cancer? Trump’s EPA Will Decide
Roundup has revolutionized farming. Now, human health and Bayer’s $66 billion deal for Monsanto depend on an honest appraisal of its safety.
Oh no, MON bagholders still holding out hope...Where if FUNFUN?
Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
Q3 results are next week. These should be pretty good due to cost cutting, whether it is soy or corn its good fro MON. They have made deals with Dupont etc on soybeans and so they should be reaping that harvest and insiders appear to have been excusing their options in the window they have - which is now closed -- but reality is the stock price is now dependent on merger with a price cap of $128 so we will have to wait until EU and US start OKing merger beore it will move much above $120. Logically based on amrket share the merger is safe it will depend on politics if there are issues. BAyer has agreed to sell the overlapping products so there is far less market overlap with this than Dupont Dow had. The merger with BAyer woudl have zero effect on corn, soy, cotton, canola seed market share and since Monsanto really only sold glyphosate as a pesticide and BAyer is selling off the gluphosinate there are no anti-trust market share issues. The Europeans also shouldn't compalin about an EU company buying American -usualy the compalin about the reverse. It also woudln't affect jobs that much in the US
The trading setup for MON looks very enticing. check out awe_some_stock.s, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
If we are to go off the RSI then you could argue that a pull back next day or so could occur on MON before rallying up. check out awe_some_stocks, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
I would have preferred a cash and stock deal so MON would continue to see upside as BAYRY stock price moves up. I wonder why the deal was structured as all cash. Oh well.
I sure hope the Bayer/Monsanto deal falls though. I like having Mon a US company and I hate paying capital gains. I am perfectly content to collect dividends forever.